Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Julia Elisabeth Fromme, Katja Schmitz, Astrid Wachter, Marius Grzelinski, Dirk Zielinski, Christina Koppel, Lena-Christin Conradi, Kia Homayounfar, Tabea Hugo, Sara Hugo, Laura Lukat, Josef Rüschoff, Philipp Ströbel, Michael Ghadimi, Tim Beißbarth, Kirsten Reuter-Jessen, Annalen Bleckmann, Hans-Ulrich Schildhaus
Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32204-32218
Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci
Published Aug 14, 2018 · Vol. 9, No. 63 · pp. 32182-32190
Mirelle Lagendijk, Sepideh Saadatmand, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst, Vanja de Weerd, Raquel RamÃrez-Moreno, Marcel Smid, Anieta M. Sieuwerts, John W.M. Martens
Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 32096-32096